Agenus Capital Surpluse from 2010 to 2025

AGEN Stock  USD 1.67  0.03  1.83%   
Agenus Capital Surpluse yearly trend continues to be very stable with very little volatility. Capital Surpluse is likely to drop to about 1.1 B. During the period from 2010 to 2025, Agenus Capital Surpluse quarterly data regression pattern had sample variance of 176372.9 T and median of  1,005,183,033. View All Fundamentals
 
Capital Surpluse  
First Reported
2011-06-30
Previous Quarter
1.6 B
Current Value
1.7 B
Quarterly Volatility
329.7 M
 
Yuan Drop
 
Covid
Check Agenus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Agenus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 14 M, Interest Expense of 123.5 M or Selling General Administrative of 75.5 M, as well as many indicators such as Price To Sales Ratio of 0.54, Dividend Yield of 0.0018 or Days Sales Outstanding of 1.36. Agenus financial statements analysis is a perfect complement when working with Agenus Valuation or Volatility modules.
  
Check out the analysis of Agenus Correlation against competitors.

Latest Agenus' Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of Agenus Inc over the last few years. It is Agenus' Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Agenus' overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

Agenus Capital Surpluse Regression Statistics

Arithmetic Mean1,060,648,349
Geometric Mean987,366,817
Coefficient Of Variation39.60
Mean Deviation338,043,831
Median1,005,183,033
Standard Deviation419,967,714
Sample Variance176372.9T
Range1.3B
R-Value0.89
Mean Square Error40024.6T
R-Squared0.79
Slope78,314,023
Total Sum of Squares2645593.2T

Agenus Capital Surpluse History

20251.1 B
20241.9 B
20221.6 B
20211.5 B
20201.3 B
20191.1 B
2018B

About Agenus Financial Statements

Agenus investors utilize fundamental indicators, such as Capital Surpluse, to predict how Agenus Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Surpluse1.9 B1.1 B
When determining whether Agenus Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Agenus' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Agenus Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Agenus Inc Stock:
Check out the analysis of Agenus Correlation against competitors.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.59)
Revenue Per Share
4.818
Quarterly Revenue Growth
(0.68)
Return On Assets
(0.29)
Return On Equity
(12.79)
The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.